Articles

Find an Article

Filter articles

Showing 591 to 600 of 675 results

Protecting plant products in Europe

EU16-10-2013Frances Salisbury and Lindsey Woolley

Frances Salisbury and Lindsey Woolley look at the complex business of patenting agricultural products in Europe.

Room for improvement: enforcing data exclusivity provisions in Mexico

Mexico16-10-2013Jose Trigueros

In Mexico, it can be tricky to protect data exclusivity, but prospective international agreements may provide a solution, as Jose Trigueros explains.

Enough is enough: sufficiency and technical contribution

EU, US16-10-2013

In the life sciences sector, defending broad patent claims can be a tricky business, says Gordon Wright.

Salad days: tomatoes, broccoli and radish patents

EU16-10-2013Margreet van Heuvel and Bart Swinkels

When it comes to plants, European courts have been occupied with various debates over salad. Margreet van Heuvel and Bart Swinkels take a look.

'Because he fears': should generics fear the high court's quia timet injunctions?

UK16-10-2013Bethan Hopewell and Geraldine Quinn

For generic drug makers, previous bad behaviour may affect new litigation, especially when it comes to injunctions, as Bethan Hopewell and Geraldine Quinn explain.

A giant's perspective: interview with Bayer

Germany, India16-10-2013

LSIPR spoke to Jörg Thomaier, chief IP counsel at Bayer, about the state of protection in emerging jurisdictions and the challenges the global company faces in asserting its IP across the world.

Courting controversy: the implications of Brüstle

EU, Germany16-10-2013

The Court of Justice of the European Union’s decision in the Brüstle case has worrying implications for some stem cell patents. Andy Sanderson looks at the landscape across Europe.

The priority trap: new disclosure requirements in Germany

Germany16-10-2013

A German Federal Court decision has given patent applicants in the life sciences field plenty to think about, as Wolfgang Bublak and Axel Berger explain.

AIPPI 2013: Pharmaceutical products and the trademark hiccup

30-09-2013

The annual International Association for the Protection of IP (AIPPI) conference in Helsinki, Finland, assessed the potential problems for pharmaceutical companies trying to brand their medicinal products.

Big player: the Bavarian biotech cluster

Germany30-09-2013

With a track record of successful innovation, Munich is one of the leading lights of European biotech. LSIPR went to visit.

Showing 591 to 600 of 675 results

LSIPR